Hyaluronidase drug data and news

---

Halozyme Therapeutics Completes Enrollment of Chemophase Phase I ...  07 Mar 2006
The company has received FDA approval for two products: Cumulase(TM), the first and only recombinant human hyaluronidase for cumulus removal in the IVF process ... - PR Newswire (press release),

Halozyme Therapeutics and Baxter Release Results From the INFUSE ...  Feb 8, 2006
Hylenex is a liquid injectable formulation that includes the active pharmaceutical ingredient, recombinant human hyaluronidase (rHuPH20), which is approved by ... - PharmaLive.com (press release),

Halozyme Therapeutics Initiates Clinical Trial of Subcutaneous ...  Feb 2, 2006
Hylenex is a liquid injectable formulation that includes the active pharmaceutical ingredient, recombinant human hyaluronidase (rHuPH20). ... - PR Newswire (press release),

Halozyme Therapeutics and Baxter Release Results From the INFUSE ...  Feb 8, 2006
Hylenex is a liquid injectable formulation that includes the active pharmaceutical ingredient, recombinant human hyaluronidase (rHuPH20), which is approved by ... - Yahoo! News (press release)

Halozyme Therapeutics Initiates Clinical Trial of Subcutaneous ...  Feb 2, 2006
Hylenex is a liquid injectable formulation that includes the active pharmaceutical ingredient, recombinant human hyaluronidase (rHuPH20). ... - PR Newswire (press release),

ISTA Pharmaceuticals Announces Acceptance of ISTA's European ...  Jan 12, 2006
...accepted for review ISTA's centralized Marketing Authorisation Application (MAA) seeking European market approval of Vitragan(TM) (Ovine Hyaluronidase) for the ... - PR Newswire (press release),

Research Supports Effectiveness Of Biocell Collagen II(r) In ...  Jan 19, 2006
ANAHEIM, CA, January 19, 2006 - A new bioassay report states the effectiveness of BioCell Collagen II(r) with hyaluronic acid (HA) in inhibiting hyaluronidase. ... - NPIcenter (press release),

Halozyme advances trial of absorption agent  Jan 25, 2006
The company is testing Hylenex, a liquid injectable formulation that includes the active pharmaceutical ingredient recombinant human hyaluronidase (rHuPH20). ... - Pharmaceutical Business Review

Bioassay supports skin benefit of BioCell ingredient  Jan 20, 2006
Degradation of HA is thought to be the work of an enzyme called hyaluronidase. The study, commissioned by AIBMR Life Sciences, showed ... - NutraIngredients-usa.com,

ISTA's eye treatment under EU review  Jan 12, 2006
12 Jan 2006, 17:44 GMT - Vitragan is ISTA's proprietary formulation of highly purified ovine hyaluronidase, which is commonly known in the US as vitrase. ... - Pharmaceutical Business Review

ProMetic Product Used in the Manufacture of an FDA-Approved ...  Jan 16, 2006
...of PLI's subsidiary ProMetic BioSciences Ltd, has received US Food and Drug Administration (FDA) approval for Hylenex recombinant (hyaluronidase human injection ... - CCNMatthews (press release),

Groundbreaking Research Into Deadly Diseases  12 Dec 2005
...a team from Northumbria University's School of Applied Sciences, has isolated one of the main enzymes implicated in disease - known as a hyaluronidase, HylP1. ... - Medical News Today (press release),

Approval Marks the First Recombinant Human Hyaluronidase Approved ...  Dec 5, 2005
Healthcare Corporation announced today that the US Food and Drug Administration (FDA) has approved Halozyme's Hylenex recombinant (hyaluronidase human injection ... - DG News

FDA Approvals: Angiomax, Depakote ER, Hylenex  Dec 8, 2005
...extended-release tablets for the treatment of acute manic or mixed episodes associated with bipolar disorder; and recombinant hyaluronidase human injection for ... - Medscape (subscription)

Halozyme Therapeutics and Baxter Healthcare Corporation Announce ...  Dec 5, 2005
Approval Marks the First Recombinant Human Hyaluronidase Approved for Use as an Adjuvant Drug to Increase the Absorption and Dispersion of Other Injected Drugs ... - PR Newswire (press release),

Breeding Globally--AI Advances  Dec 1, 2005
...total number of sperm present within a sample is reflected in the concentration of certain enzymes found within sperm--for example, hyaluronidase and acrosin ... - TheHorse.com,

Halozyme Therapeutics Reports Third Quarter 2005 Financial Results  Nov 11, 2005
The presentation of new pharmacokinetic and efficacy data with a novel, chemically modified form of a recombinant human hyaluronidase enzyme in animal ... - PR Newswire (press release),

Intimate Allergies  Nov 29, 2005
...group antigens, calcium, chlorine, cholesterol, choline, citric acid, creatine, deoxyribonucleic acid, fructose, glutathione, hyaluronidase, inositol, lactic ... - About - News & Issues,

Smashing sperm caps  Nov 21, 2005
...extensively deformed. Pure enzyme injections (such as trypsin and hyaluronidase) caused similar levels of malformation. Human being ... - Deccan Herald,

ISTA Pharmaceuticals Reports Third Quarter 2005 Financial Results  Nov 8, 2005
...the Center for Medicare and Medicaid Services(CMS) has granted two new national J-Codes covering the injection of preservative free ovine hyaluronidase, Vitrase ... - PharmaLive.com (press release),

ISTA Pharmaceuticals Announces VITRASE(R) Spreading Agent and ...  Sep 19, 2005
...(Nasdaq: ISTA) today announced its Fall 2005 schedule for presenting clinical data on its product, Vitrase(R) (Ovine Hyaluronidase), which is currently FDA ... - PR Newswire (press release),

ISTA Pharmaceuticals Announces VITRASE Spreading Agent and Adjunct ...  Sep 19, 2005
...today announced its Fall 2005 schedule for presenting clinical data on its product, Vitrase(R) (Ovine Hyaluronidase), which is currently FDA approved for use ... - PharmaLive.com (press release),

Halozyme Therapeutics Presents Novel Stroke Data at the 2005 ...  Sep 27, 2005
...- Modified Recombinant Human Hyaluronidase Demonstrates Increased Survival in Preclinical Stroke Models - SAN DIEGO, Sept. 27 /PRNewswire ... - PR Newswire (press release),

Halozyme Therapeutics Presents Novel Stroke Data at the 2005 ...  Sep 27, 2005
...human enzymes, presented new pharmacokinetic and efficacy data with a novel, chemically modified form of a recombinant human hyaluronidase enzyme in animal ... - PharmaLive.com (press release),

Halozyme Therapeutics Provides Update on Hylenex New Drug ...  Sep 26, 2005
US Food and Drug Administration (Agency) on Friday regarding Halozyme's new drug application (NDA) for Hylenex(TM) recombinant (hyaluronidase human injection ... - PR Newswire (press release),

ISTA Pharmaceuticals Announces Publication of Vitrase Phase III ...  Sep 7, 2005
...safety and efficacy findings of the Company's two randomized, double-masked, placebo- controlled Phase III studies of Vitrase® (Ovine Hyaluronidase) for the ... - Yahoo! News (press release)

Halozyme Therapeutics Receives FDA Clearance to Initiate ...  Aug 11, 2005
Based on the promising pre-clinical data gathered to date, and the previous clinical work done with bovine hyaluronidase in bladder cancer, co-delivery of ... - PR Newswire (press release),